angiotensin IV comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
While some forms of aquaculture can be devastating to ecosystems, such as shrimp farming in mangroves, other forms can be beneficial. Shellfish aquaculture adds substantial filter feeding capacity to an environment which can significantly improve water quality. A single oyster can filter 15 gallons of water a day, removing microscopic algal cells. By removing these cells, shellfish are removing nitrogen and other nutrients from the system and either retaining it or releasing it as waste which sinks to the bottom. By harvesting these shellfish, the nitrogen they retained is completely removed from the system. Raising and harvesting kelp and other macroalgae directly remove nutrients such as nitrogen and phosphorus. Repackaging these nutrients can relieve eutrophic, or nutrient-rich, conditions known for their low dissolved oxygen which can decimate species diversity and abundance of marine life. Removing algal cells from the water also increases light penetration, allowing plants such as eelgrass to reestablish themselves and further increase oxygen levels. Aquaculture in an area can provide for crucial ecological functions for the inhabitants. Shellfish beds or cages can provide habitat structure. This structure can be used as shelter by invertebrates, small fish or crustaceans to potentially increase their abundance and maintain biodiversity. Increased shelter raises stocks of prey fish and small crustaceans by increasing recruitment opportunities in turn providing more prey for higher trophic levels.
Austria achieved some initial victories against the thinly spread army of Marshal Berthier. Napoleon left Berthier with only 170,000 men to defend France's entire eastern frontier (in the 1790s, 800,000 men had carried out the same task, but holding a much shorter front). In the east, the Austrians drove into the Duchy of Warsaw but did not achieve their objectives at the Battle of Raszyn on 19 April 1809. The Army of the Duchy of Warsaw captured West Galicia following its earlier success. Napoleon assumed personal command and bolstered the army for a counter-attack on Austria. After a few small battles, the well-run campaign forced the Austrians to withdraw from Bavaria, and Napoleon advanced into Austria. His hurried attempt to cross the Danube resulted in the major Battle of Aspern-Essling (22 May 1809) – Napoleon's first significant tactical defeat. But the Austrian commander, Archduke Charles, failed to follow up on his indecisive victory, allowing Napoleon to prepare and seize Vienna in early July. He defeated the Austrians at Wagram, on 5–6 July. (It was during the middle of that battle that Marshal Bernadotte was stripped of his command after retreating contrary to Napoleon's orders. Shortly thereafter, Bernadotte took up the offer from Sweden to fill the vacant position of Crown Prince there. Later he actively participated in wars against his former Emperor.)
The lack of HAND1 detection in the developing embryo leads to many of the structural defects that causes heart disease and facial deformities while the dosage of HAND1 relates to the severity of these maladies. HAND factors function in the formation of the right ventricle, left ventricle, aortic arch arteries, epicardium, and endocardium implicating them as mediators of congenital heart disease. In addition, HAND1 is uniquely expressed in trophoblasts and is essential for early trophoblast differentiation.
=== Japan === In Japan, drugs and medical devices are given the designation as an orphan drug or device based on the Act of Securing Quality, Efficacy, Safety of Pharmaceuticals, Medical Devices, Regenerative or Cellular Therapy Products, Gene Therapy Products, and Cosmetics if they are intended for use in less than 50,000 patients in Japan for which there is a high medical need.
== Conferences == The society's annual meeting is held in the first week of September as well as regular special interest group meetings (Lipidomics, MALDI & Imaging, Ambient Ionisation, Environmental & Food Analysis) through the year, in locations throughout the United Kingdom. Locations of the society's annual meetings beginning in 1965:
Sources: en.wikipedia.org
Usage within the Hindu and Buddhist cultures of the Indian subcontinent is common, with many street vendors in India openly selling products infused with cannabis, and traditional medical practitioners in Sri Lanka selling products infused with cannabis for recreational purposes and well as for religious celebrations. Indian laws criminalizing cannabis date back to the colonial period. India and Sri Lanka have allowed cannabis to be taken in the context of traditional culture for recreational/celebratory purposes and also for medicinal purposes. On 17 October 2015, Australian health minister Sussan Ley presented a new law that will allow the cultivation of cannabis for scientific research and medical trials on patients. On 17 October 2018, Canada legalized cannabis for recreational adult use making it the second country in the world to do so after Uruguay and the first G7 nation. This legalization comes with regulation similar to that of alcohol in Canada, age restrictions, limiting home production, distribution, consumption areas and sale times. Laws around use vary from province to province including age limits, retail structure, and growing at home. The Canadian Licensed Producer system aims to become the Gold Standard in the world for safe and secure cannabis production, including provisions for a robust craft cannabis industry where many expect opportunities for experimenting with different strains.
During the later part of the 18th century, fundamental internal reforms were attempted in the Polish–Lithuanian Commonwealth as it slid into extinction. The reform activity, initially promoted by the magnate Czartoryski family faction known as the Familia, provoked a hostile reaction and military response from neighboring powers, but it did create conditions that fostered economic improvement. The most populous urban center, the capital city of Warsaw, replaced Danzig (Gdańsk) as the leading trade center, and the importance of the more prosperous urban social classes increased. The last decades of the independent Commonwealth's existence were characterized by aggressive reform movements and far-reaching progress in the areas of education, intellectual life, art and the evolution of the social and political system. The royal election of 1764 resulted in the elevation of Stanisław August Poniatowski, a refined and worldly aristocrat connected to the Czartoryski family, but hand-picked and imposed by Empress Catherine the Great of Russia, who expected him to be her obedient follower. Stanisław August ruled the Polish–Lithuanian state until its dissolution in 1795. The king spent his reign torn between his desire to implement reforms necessary to save the failing state and the perceived necessity of remaining in a subordinate relationship to his Russian sponsors. The Bar Confederation (1768–1772) was a rebellion of nobles directed against Russia's influence in general and Stanisław August, who was seen as its representative, in particular.
== Performing with the Grateful Dead == In early 1970, Lagin initiated a correspondence with Jerry Garcia after seeing the Grateful Dead at the Boston Tea Party in 1969. In May 1970, he helped facilitate a concert and free live outdoor performance featuring the band at MIT that coincided with the Kent State shootings. That summer, Lagin, at Garcia's invitation, visited San Francisco and contributed piano to "Candyman" during the American Beauty album sessions, played in several jams, and started what would become close friendships with Garcia, bassist Phil Lesh, and David Crosby. From 1970 to 1975, Lagin contributed Hammond B3 organ, electric piano, and clavichord to material of his choice (primarily—but not exclusively—songs with long instrumental passages) at several Grateful Dead concerts. His first performances with the Grateful Dead were on November 5 and November 8, 1970 at the Capitol Theater in Port Chester, New York; his first complete concert was at Boston University's Sargent Gym on November 21, 1970. During many 1974 Grateful Dead concerts over several tours, including Europe, he performed a middle set of electronic music, including parts of his composition Seastones, on computer-controlled analog synthesizers with Phil Lesh on electronically processed bass. Some sets included Jerry Garcia playing guitar filtered through effects processors and Bill Kreutzmann on drums; these sets occasionally segued into the final Grateful Dead set, with Lagin performing with the Dead, including an appearance in The Grateful Dead Movie.
Adrenomedullin (AM) exerts its actions through combinations of the calcitonin receptor-like receptor (CALCRL) or CLR; and either (Receptor activity-modifying protein) 2 (RAMP2) or RAMP3, (known as AM1 and AM2 receptors, respectively). Both transduce the hormone binding to intracellular signaling via second messenger cascades. The AM2 receptor has a low affinity for CGRP, but this is of no physiological relevance. Unlike the classical one ligand-one receptor notion of receptor signalling, the interaction of both CALCRL and RAMP at the membrane is required for AM to mediate its action: neither can bind the hormone (and therefore transduce a signal) alone. Stimulation by AM of its receptor increases production of both cyclic AMP (cAMP) and nitric oxide. Before the discovery of the RAMPs and the identification of heteromeric receptors for the calcitonin family of peptides, a single G Protein coupled Adrenomedullin receptor was identified, but more recent reports have cast doubts as to its importance in the major effects of adrenomedullin. In more recent research, the roles of the AM1 and AM2 receptors have been clarified through studies in genetically manipulated mice. The adrenomedullin knockout is an embryonic lethal phenotype that dies mid-gestation from a condition known as hydrops fetalis. The CALCRL or CLR KO mouse recapitulates the same phenotype, as it lacks both the AM1 and AM2 receptors (incidentally confirming the lack of physiological significance for the earlier single protein AM receptor discovered by Kapas).
Sources: en.wikipedia.org
Cabinet mandate letters requested by the Canadian Broadcasting Corporation through a freedom of information request were not released to the public, despite being ordered to by the Ontario information and privacy commissioner in 2019. The Supreme Court of Canada held the mandate letters issued by Doug Ford to his ministers were protected from disclosure under access to information legislation, under the principle of Cabinet confidentiality. In 2026, the government announced changes to Ontario's existing freedom of information (FOI) laws, restricting access to government records from the premier's office, Cabinet ministers, and parliamentary assistants. The legislation faced backlash from opposition parties and Ontario's privacy commissioner.
=== Autolytic debridement === Autolysis uses the body's own enzymes and moisture to re-hydrate, soften and finally liquefy hard eschar and slough. Autolytic debridement is selective; only necrotic tissue is liquefied. It is also virtually painless for the patient. Autolytic debridement can be achieved with the use of occlusive or semi-occlusive dressings which maintain wound fluid in contact with the necrotic tissue. Autolytic debridement can be achieved with hydrocolloids, hydrogels and transparent films. It is suitable for wounds where the amount of dead tissue is not extensive and where there is no infection.
In July 2018, Tim Hortons announced that they would open 1,500 stores in China. The first of these opened on February 26, 2019, in Huangpu District, Shanghai. By December 31, 2024, the number of stores nationwide has reached 1,022, covering 82 cities. The first Tim Hortons location in Thailand opened on January 18, 2020, at Samyan Mitrtown Mall in Bangkok through a franchise partnership with Thailand-based WeEat Co. As of January 2021, there are 10 locations operating in the country. The first two Tim Hortons locations in India opened on August 11, 2022, in New Delhi and Gurugram, followed by a third location, in New Delhi, on August 31, 2022. On February 11, 2023, Tim Hortons opened four locations in DHA, Lahore, and Gulberg, and announced to open more locations in other major cities of Pakistan. In January 2024, Tim Hortons opened another store in Pakistan, this time in Islamabad. In 2023, Japanese conglomerate Marubeni Corporation announced that they were planning to open a Tim Hortons location in Singapore, Malaysia, and to open another in Indonesia, in 2024. The location in Singapore officially opened at VivoCity on November 17, 2023. On August 30, 2024, Tim Hortons opened its first ever Tim's Signature at 313@Somerset, Singapore which sells more upmarket coffee options, such as single-origin and filter brews. As of December 2025, Tim Hortons has 15 outlets in Singapore including Tim's Signature. In 2026, Tim Hortons Singapore became halal-certified.
The water activity, aw, in a fish is defined as the ratio of the water vapour pressure in the flesh of the fish to the vapour pressure of pure water at the same temperature and pressure. It ranges between 0 and 1, and is a parameter that measures how available the water is in the flesh of the fish. Available water is necessary for the microbial and enzymatic reactions involved in spoilage. There are a number of techniques that have been or are used to tie up the available water or remove it by reducing the aw. Traditionally, techniques such as drying, salting and smoking have been used, and have been used for thousands of years. These techniques can be very simple, for example, by using solar drying. In more recent times, freeze-drying, water-binding humectants, and fully automated equipment with temperature and humidity control have been added. Often a combination of these techniques is used.
A clinical study that includes a comparison (control) group. The comparison group receives a placebo, another treatment, or no treatment at all. (NCI) An experiment or clinical trial that includes a comparison (control) group. (NCI) Controlled trials
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.